Steven K. Davidsen - Concepedia

Author

Steven K. Davidsen

Also Known As

Patrick A. Marcotte, S K Davidsen, S. DAVIDSEN, S. Davidsen, S. K. DAVIDSEN, S. K. Davidsen, S.K Davidsen, S.K. Davidsen, STEVEN K. DAVIDSEN, Steven Davidsen

120

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United States)Abbott (United Kingdom)

About

Steven K. Davidsen is an author at Abbott Fund specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	48	3K
2	Natural Sciences	25	31	2.1K
3	Engineering	4	4	326
4	Health Sciences	1	1	13
5	Allergy	1	1	17

Steven K. Davidsen

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Keith B. Glaser, Michael J. Staver, Jeffrey F. Waring, PubMed Histone ModificationsHdac InhibitorsEpigenetic ChangeMultiple Histone DeacetylaseGene Expression Profiling	2003	524
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR Philip J. Hajduk, George S. Sheppard, David G. Nettesheim, Journal of the American Chemical Society	1997	316
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA Keith B. Glaser, Junling Li, Michael J. Staver, Biochemical and Biophysical Research Communications Histone ModificationsTumor BiologyChromatinChromatin RemodelingCarcinoma Cells	2003	218
Discovery of<i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor Yujia Dai, Kresna Hartandi, Zhiqin Ji, Journal of Medicinal Chemistry Compound 17PDrug TargetChemoprevention StrategyKinase InhibitorsPharmacotherapy	2007	180
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Blood	2009	160
Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors Yujia Dai, Yan Guo, Robin R. Frey, Journal of Medicinal Chemistry Drug TargetPharmacotherapyPharmaceutical ChemistryThienopyrimidine UreasTumor Biology	2005	152
Trifluoromethyl ketones as inhibitors of histone deacetylase Robin R. Frey, Carol K. Wada, Robert B. Garland, Bioorganic & Medicinal Chemistry Letters Histone ModificationsChromatinMedicinal ChemistryBiochemistryChromatin Remodeling	2002	147
Total synthesis of (.+-.)-methyl homodaphniphyllate Clayton H. Heathcock, Steven K. Davidsen, Sander G. Mills, Journal of the American Chemical Society EngineeringAltmetric Attention ScoreOrganic ChemistryChemistryHomodaphniphyllateclayton H. Heathcock	1986	115
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC) Michael L. Curtin, Robert B. Garland, H. Robin Heyman, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistrySuccinimide Hydroxamic AcidsBiochemistryNatural SciencesMedicine	2002	113
Phenoxyphenyl Sulfone<i>N</i>-Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors Carol K. Wada, James H. Holms, Michael L. Curtin, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceChemoprevention StrategyBiochemistryMedicine	2001	102

Page 1